copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Vertex Pharmaceuticals | Home At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases We’re focused on discovering, developing and producing innovative medicines so people with serious diseases can lead better lives
Vertex Inc. : Tax Technology Software Solutions for Businesses Vertex connects real-time rates, rules, exemptions, and cross-border logic directly to your ERP and financial processes This helps you reduce risk, maintain agility, and transform tax complexity into a competitive advantage
Vertex Stock Soars as Breakthrough Kidney Drug Seeks U. S. Approval Vertex’s stocks have been trading up by 8 24 percent following positive momentum from breakthrough developments in gene-editing therapy Key Highlights: Shares jump 7% to $492 after announcing the successful Phase 3 trial of Povetacicept, a promising kidney disease drug Interim results from the ongoing RAINIER study show significant benefits and a potential best-in-class treatment Positive […]
Vertex rises after kidney drug meets goal in late-stage trial Vertex Pharmaceuticals Inc shares rose as much as 11 percent in late trading Monday after the biotech company said its drug to treat a kidney disorder met its goal in a late-stage trial
Vertex Pharmaceuticals Surges as Breakthrough Kidney Data Sets New Gold . . . Shares of Vertex Pharmaceuticals (Nasdaq: VRTX) climbed more than 8% today, reaching a record high as the biotechnology giant unveiled spectacular interim results from its pivotal Phase 3 RAINIER trial The data, which focused on povetacicept for the treatment of IgA nephropathy (IgAN), showcased a 52% reduction in proteinuria, a key marker of kidney disease progression This breakthrough not
Vertexs kidney disease drug meets main goal in late-stage trial Vertex Pharmaceuticals said on Monday that its experimental drug sharply reduced a key sign of kidney damage in a late‑stage trial, putting the company on track to seek U S approval by the